By proceeding, you agree to our Terms of Use and Privacy Policy.
Welcome to the Optimizing AAV Safety Summit: Predict & Monitor AAV Safety Signals to De-Risk Genetic Therapy Development Hundreds of clinical trials using AAV are underway, with several hundred more in preclinical development.
Gain insights on optimizing AAV safety processes & benefit-risk analysis.
Join key biotech and pharma leaders like Spark Therapeutics, Ask Bio, Eli Lilly, Takeda & more in the AAV space about safe & effective genetic therapies.
Learn how clinical safety signals have transformed firms' pipeline evolution & obtain implementable lessons to strengthen your clinical/preclinical programs.
Step into the future of risk-free Gene therapy with Adam Shaywitz- BridgeBio; Victoria Best- AmplifyBio; Jeffry Lawrence- SSI Strategy & others.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
AmplifyBio combines the strength, knowledge and experience of our partners, and the expertise of our cross-integrated teams to advance translational science, cell and gene therapies and next-generation medicines for the benefit of millions of people
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.